Diluted HEPS 26cps compared to -6cps LY.
Revenue from continuing operations improved by 20.9% y-y to R6 172m, driven by the Zimbabwean operations which increased its revenue by 104% y-y and did not incur any material hyperinflation losses in the period.
GPM increased from 16.7% to 20.1%.
OPM rose from 5.3% to 10.9%.
Expenses decreased by 2.8% y-y, expense-to-sales ratio fell by 220bps to 9.1%.
No dividend.
Gross debt down 25.5% y-y to R1 016m.
Cash flow from operating activities improved by 51.4% y-y to R775m.
Sale of 51% stake in CIMERWA concluded on 17 November for $42.5m.
Shares to the value of R103m repurchased during the period, just over half the R200m approved for share repurchases.
